|
|
|
Insider
Information: |
Beshar Luke M |
Relationship: |
Director |
City: |
East Rutherford |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
198,000 |
|
Indirect Shares
|
1,081 |
|
|
Direct
Value |
$556,380 |
|
|
Indirect Value
|
$64,795 |
|
|
Total
Shares |
199,081 |
|
|
Total
Value |
$621,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-4.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cambrex Corp |
CBM |
Executive Vice President |
2007-10-10 |
0 |
2005-12-31 |
1,081 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
EVP & CFO |
2015-02-21 |
0 |
2011-01-31 |
0 |
Premium* |
|
Regenxbio Inc. |
RGNX |
|
2018-11-29 |
0 |
2018-11-19 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2022-06-30 |
198,000 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-02-19 |
4 |
D |
$8.01 |
$55,029 |
D/D |
(6,870) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
66,050 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-04-10 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-04-10 |
4 |
AS |
$12.00 |
$600,220 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-04-29 |
4 |
AS |
$14.00 |
$67,900 |
D/D |
(4,850) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-04-29 |
4 |
OE |
$4.05 |
$19,643 |
D/D |
4,850 |
64,030 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-05-09 |
4 |
OE |
$4.05 |
$182,858 |
D/D |
45,150 |
104,330 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-05-09 |
4 |
AS |
$14.18 |
$640,001 |
D/D |
(45,150) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-16 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-16 |
4 |
AS |
$27.89 |
$1,394,576 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-20 |
4 |
OE |
$5.71 |
$286,200 |
D/D |
50,000 |
109,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-09-20 |
4 |
AS |
$30.05 |
$1,512,875 |
D/D |
(50,000) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-12 |
4 |
AS |
$24.02 |
$1,448,387 |
D/D |
(60,311) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-12 |
4 |
OE |
$8.21 |
$496,735 |
D/D |
60,311 |
119,491 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-26 |
4 |
OE |
$3.34 |
$195,822 |
D/D |
37,874 |
97,054 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2013-12-26 |
4 |
AS |
$30.02 |
$1,136,977 |
D/D |
(37,874) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-01-08 |
4 |
OE |
$3.34 |
$105,504 |
D/D |
31,588 |
90,768 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-01-08 |
4 |
AS |
$35.01 |
$1,105,896 |
D/D |
(31,588) |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-02-07 |
4 |
D |
$35.13 |
$163,319 |
D/D |
(4,649) |
54,531 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,967 |
59,180 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,530 |
65,061 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-02-13 |
4 |
D |
$38.30 |
$209,080 |
D/D |
(5,459) |
59,602 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-08-13 |
4 |
OE |
$3.34 |
$185,915 |
D/D |
53,813 |
113,415 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-10-27 |
4 |
AS |
$26.75 |
$819,606 |
D/D |
(30,635) |
82,780 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
|
2014-10-31 |
4 |
AS |
$29.00 |
$290,000 |
D/D |
(10,000) |
72,780 |
0 |
- |
|
77 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|